<DOC>
	<DOCNO>NCT00701896</DOCNO>
	<brief_summary>People infect HIV appear especially susceptible adverse effect cigarette smoking . The purpose study determine quit smoke use specialized smoking cessation treatment prevent one developing accelerate lung damage , particularly emphysema .</brief_summary>
	<brief_title>Smoking Cessation Using Motivational Therapy Varenicline</brief_title>
	<detailed_description>HIV-infected smoker increase risk life-threatening disease , pneumonia . To date , little known tobacco consumption characteristic at-risk population smoker , well document high risk smoking-related co-morbidities . In addition , effective cessation strategy describe HIV-infected population . A specialized smoking cessation combine recommendation exist scientifically-valid clinical guideline Motivational Interviewing new pharmacotherapeutic agent , may effective mechanism apply vulnerable population smoker . This initial , efficacy investigation potential guide future treatment research pertain tobacco cessation , respiratory illness HIV .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>1 . 18 year age old ; 2. diagnosis HIV ; 3. selfreported smoke daily basis ; 4. provide inform write consent 1. person active psychosis impair mental status judge clinic staff confirm MiniMental Status Exam ) 2. unable understand speak English 3. age less 18 year . 4. pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>HIV</keyword>
	<keyword>Positive</keyword>
	<keyword>Smokers</keyword>
	<keyword>Varenicline</keyword>
</DOC>